Identification of Functional Interactome of Gastric Cancer Cells with Helicobacter pylori Outer Membrane Protein HpaA

Ruyue Fan1, Xiurui Han1, Di Xiao1

  • 1State Key Laboratory of Infectious Disease Prevention and Control, Collaborative Innovation Center for Diagnosis and Treatment of Infectious Diseases, National Institute for Communicable Disease Control and Prevention, Chinese Center for Disease Control and Prevention, Beijing, China.

Insights

Helicobacter pylori outer membrane protein HpaA interacts with gastric epithelial cells. Researchers identified ANXA2 as a key binding partner, suggesting new targets for anti-adhesion drugs.

Area of Science:

  • Microbiology
  • Molecular Biology
  • Cell Biology

Background:

  • Helicobacter pylori (H. pylori) outer membrane protein HpaA is crucial for bacterial adhesion to the human stomach.
  • The precise functional relationship between HpaA and gastric epithelial cells remains unclear.

Purpose of the Study:

  • To investigate the interactions between HpaA and cellular proteins in gastric epithelial cells.
  • To identify potential HpaA binding partners involved in H. pylori adhesion.

Main Methods:

  • Recombinant HpaA protein from H. pylori 26695 was expressed, purified, and characterized using Circular Dichroism (CD) spectroscopy.
  • Pull-down assays were performed using purified HpaA and lysates from gastric cancer cell lines (AGS and SGC-7901).
  • Proteins interacting with HpaA were identified using high-performance liquid chromatography tandem mass spectrometry (HPLC-MS/MS).

Main Results:

  • A total of 9 and 13 proteins were identified from AGS and SGC-7901 cell lysates, respectively.
  • Annexin A2 (ANXA2) was consistently identified as a high-scoring putative HpaA functional partner in both cell lines.
  • HpaA may be involved in regulating transcription and nucleic acid metabolism during H. pylori adhesion.

Conclusions:

  • ANXA2 is a potential functional partner of HpaA in gastric epithelial cells.
  • HpaA-binding proteins, such as ANXA2, represent potential therapeutic targets for developing anti-adhesion drugs against H. pylori infections.